Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation Controversies and Advances 2025

Cuffless blood pressure devices: Are they ready for prime time?

Presenter: Jennifer L. Cluett

January 30, 2025

Presentation Miami Valves 2024

New Cerebral Protection Devices for TAVR

Presenter: Fábio S. Brito Jr.

February 03, 2024

Presentation TCT 2023

Animal Studies of Cardiovascular Devices: The New CDRH Animal Study Guidance Document

Presenter: Natalie Miller

October 23, 2023

Presentation TCT 2023

Biocompatibility Assessment of Cardiovascular Devices: Just-in-Time Testing

Presenter: Girish Kumar

October 23, 2023

Presentation Complex Coronary Cases 2023

In-Stent Restenosis: Update and Devices

Presenter: Melissa Chang

June 16, 2023

Presentation TCT 2022

CDT: New Devices, Drugs, and Duration?

Presenter: Andrew Sharp

September 19, 2022

Presentation TCT 2022

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Presenter: Felix Mahfoud

September 17, 2022

Presentation TCT 2019

What Are the Essential Differences Between Renal Denervation Devices and Procedures, and Do They Matter?

Presenter: Philipp Lurz

September 28, 2019

Presentation TCT 2018

Implantable Devices for Pulmonary Hypertension

Presenter: Ori Ben-Yehuda, Jay S. Giri, William T. Abraham

September 22, 2018

Presentation TCT 2018

Early Feasibility Studies for Device Evaluation

Presenter: Spencer B. King III, Bram D. Zuckerman, Andrew Farb

September 21, 2018

Presentation TCT 2018

Pre-Clinical and Clinical Trial Design and Endpoints for Device Approval

Presenter: Spencer B. King III, Bram D. Zuckerman, Chris Mullin, Roseann M White

September 21, 2018

Presentation TCT 2018

Practice Guideline Requirement for New Technology

Presenter: Spencer B. King III, Bram D. Zuckerman, Alice K. Jacobs

September 21, 2018

Presentation TCT 2018

CMS Requirement for Reimbursement for Innovation

Presenter: Spencer B. King III, Bram D. Zuckerman, Lori M Ashby

September 21, 2018

Presentation TCT 2018

Regulatory Requirement for Marketing Approval including the Parallel Review, NEST, and Beyond

Presenter: Spencer B. King III, Bram D. Zuckerman

September 21, 2018

Presentation TCT 2018

ISCTR Mission and Statement of Meeting Purpose

Presenter: Nabil Dib

September 21, 2018

Presentation TCT 2017

FDA Perspectives: Devices to Control Hypertension - Patient Populations, Endpoints and Other Considerations

Presenter: Hiren Mistry, Michael A. Weber

October 31, 2017

Presentation TCT 2016

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Horst Sievert

October 30, 2016

Presentation Fellows 2016

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Presenter: Kevin Croce

April 15, 2016

Presentation Fellows 2015

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Presenter: Ajay J. Kirtane, Mauricio G. Cohen, Greg L. Kaluza

May 15, 2015

Advertisement

Cuffless blood pressure devices: Are they ready for prime time?

New Cerebral Protection Devices for TAVR

Animal Studies of Cardiovascular Devices: The New CDRH Animal Study Guidance Document

Biocompatibility Assessment of Cardiovascular Devices: Just-in-Time Testing

In-Stent Restenosis: Update and Devices

CDT: New Devices, Drugs, and Duration?

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

What Are the Essential Differences Between Renal Denervation Devices and Procedures, and Do They Matter?

Implantable Devices for Pulmonary Hypertension

Early Feasibility Studies for Device Evaluation

Pre-Clinical and Clinical Trial Design and Endpoints for Device Approval

Practice Guideline Requirement for New Technology

CMS Requirement for Reimbursement for Innovation

Regulatory Requirement for Marketing Approval including the Parallel Review, NEST, and Beyond

ISCTR Mission and Statement of Meeting Purpose

FDA Perspectives: Devices to Control Hypertension - Patient Populations, Endpoints and Other Considerations

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content